BROOKE TAYLOR: Open Payments
NPI 1528204039 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 75 payments from 18 companies in 2025. Trend: 2023 $1,381 · 2024 $1,142 · 2025 $1,213
Food & beverage: $1,213
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $289 |
| ABBVIE INC. | 18 | $220 |
| AstraZeneca Pharmaceuticals LP | 5 | $173 |
| Exact Sciences Corporation | 4 | $68 |
| PFIZER INC. | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $62 |
| Janssen Pharmaceuticals, Inc | 3 | $55 |
| Axsome Therapeutics, Inc. | 3 | $45 |
| Corcept Therapeutics | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
Products named: Rybelsus, FARXIGA, Wegovy, VRAYLAR, UBRELVY, Cologuard Collection Kit, Kerendia, SPRAVATO.
Industry payments across KY — which companies pay providers there.
